The Relation Between Preoperative ScO2 and the Postoperative Course of Humoral Organ Dysfunction Markers.

December 22, 2014 updated by: Matthias Heringlake, University of Luebeck

The Prognostic Relevance of N-terminal Pro B-type Natriuretic Peptide(NTproBNP), Cerebral Oxygen Saturation (ScO2), and Preoperative Creatinine Clearance in Cardiac Surgery Patients - Amendment 2: the Role of NTproBNP and ScO2 in Predicting Mortality and Postoperative Organ Dysfunction.

Cerebral oxygen saturation (ScO2) is a measure of cerebral and systemic oxygen delivery to demand ratio. An observational trial in a heterogeneous cohort of 1078 patients patients revealed that a ScO2 below 50% absolute during oxygen insufflation is an independent predictor of short and long term mortality in patients undergoing on-pump cardiac surgery. Comparably, a low ScO2 was a predictor of postoperative morbidity determined as a combined endpoint of a high dependency unit stay of more than 9 days and/or at least 2 of the major postoperative complications. low cardiac output syndrome, stroke, need of renal replacement therapy or reintubation.

The primary objectives of the present prospective observational study is to determine, if there is an association between preoperative ScO2 and postoperative organ dysfunction determined by sensitive markers of organ dysfunction (N-Terminal pro B-type natriuretic peptide, high sensitive troponin T, growth-differentiation factor 15, soluble -FLT1, and placental growth factor)

Study Overview

Status

Completed

Conditions

Patients Undergoing Cardiac Surgery

Study Type

Observational

Enrollment (Actual)

765

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients scheduled for cardiac surgery

Description

Inclusion Criteria:

all patients scheduled for cardiac surgery

Exclusion Criteria:

age less than 18 years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Mortality Time Frame: 1 year	1 year

Secondary Outcome Measures

Outcome Measure	Time Frame
Morbidity Time Frame: Within hospital	Within hospital

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Luebeck

Investigators

Principal Investigator: Matthias Heringlake, MD, Department of Anesthesiology, University of Luebeck

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2009

Primary Completion (Actual)

December 1, 2010

Study Completion (Actual)

December 1, 2011

Study Registration Dates

First Submitted

August 3, 2011

First Submitted That Met QC Criteria

August 3, 2011

First Posted (Estimate)

August 4, 2011

Study Record Updates

Last Update Posted (Estimate)

December 23, 2014

Last Update Submitted That Met QC Criteria

December 22, 2014

Last Verified

December 1, 2014

More Information

Terms related to this study

Keywords

Other Study ID Numbers

CS_RS_2008-2009 - ScO2

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patients Undergoing Cardiac Surgery

Vanderbilt University
GE Healthcare

Completed

Measurement of Pulmonary Transit Time by Echocardiography: Comparison With Cardiac MRI

Patients Undergoing Cardiac Surgery

United States
Seoul National University Hospital

Withdrawn

FiO2 and Outcomes After Cardiac Surgery With Cardiopulmonary Bypass

Patients Undergoing Cardiac Surgery Using Cardiopulmonary Bypass

Korea, Republic of
Yonsei University

Completed

A Comparison Between 5% Albumin and 6% Hydroxyethyl Starch 130/0.4 in Priming Solution for Cardiopulmonary Bypass and Post-bypass Maintenance Fluid in High-risk Patients

Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass

Korea, Republic of
Centre Hospitalier Universitaire Dijon

Completed

Ability of Pupillometry to Reduce Sufentanil Consumption in Planned Cardiac Surgery: Randomized, Controlled, Single-center Clinical Superiority Trial (PUCCAR)

Patients Undergoing Cardiac Surgery | Patients With Coronary Artery Bypass Surgery With CEC

France
Shaare Zedek Medical Center

Unknown

CAM in Post Surgical Management in Cardiothoracic Surgery

Patients Undergoing Open Heart Surgery | Patients Undergoing Lung Surgery

Israel
Medical University Innsbruck

Recruiting

Telemedically Assisted Optimization for Heart Failure Patients Before Cardiac Surgery to Improve Perioperative Outcome (PREPARE-HF)

Patients With Heart Failure Undergoing Cardiac Surgery

Austria
Philipps University Marburg Medical Center

Terminated

Is an Online-tool Capable of Improving Patients' Outcomes After Surgery?

Patients Undergoing Surgery

Germany
Yonsei University

Unknown

The Effect of Simple Needle Guide Device for Ultrasound-guided Internal Jugular Vein Catheterization in Surgical Patients: a Randomized-controlled Trial

Patients Undergoing Surgery

Korea, Republic of
Pharmacosmos A/S
CRO Max Neeman

Completed

A Prospective, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by Infusions to Non-Anaemic Patients Undergoing Elective or Sub-Acute Coronary Artery Bypass Graft, Valve Replacement or a Combination Thereof (CABG-01)

Non-anaemic Patients Undergoing Cardiac Surgery

Denmark
Fundacion para la Investigacion Biomedica del Hospital...
Rovi Pharmaceuticals Laboratories

Completed

Use of Bemiparine as a Prophylactic Antithrombotic Agent, in Patients Undergoing Microsurgery for Head and Neck Reconstruction

Patients Undergoing Microvascular Surgery

Spain

The Relation Between Preoperative ScO2 and the Postoperative Course of Humoral Organ Dysfunction Markers.

The Prognostic Relevance of N-terminal Pro B-type Natriuretic Peptide(NTproBNP), Cerebral Oxygen Saturation (ScO2), and Preoperative Creatinine Clearance in Cardiac Surgery Patients - Amendment 2: the Role of NTproBNP and ScO2 in Predicting Mortality and Postoperative Organ Dysfunction.

Study Overview

Status

Conditions

Study Type

Enrollment (Actual)

Participation Criteria

Eligibility Criteria

Ages Eligible for Study

Accepts Healthy Volunteers

Genders Eligible for Study

Sampling Method

Study Population

Description

Study Plan

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure

Time Frame

Secondary Outcome Measures

Outcome Measure

Time Frame

Collaborators and Investigators

Sponsor

Investigators

Study record dates

Study Major Dates

Study Start

Primary Completion (Actual)

Study Completion (Actual)

Study Registration Dates

First Submitted

First Submitted That Met QC Criteria

First Posted (Estimate)

Study Record Updates

Last Update Posted (Estimate)

Last Update Submitted That Met QC Criteria

Last Verified

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Clinical Trials on Patients Undergoing Cardiac Surgery

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations